Previous 10 | Next 10 |
SAN DIEGO, May 03, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed to save lives and improve the standard of care for patients facing serious diseases, is delivering two oral presentations highlighting n...
2023-04-24 09:13:55 ET Cidara Therapeutics ( NASDAQ: CDTX ) announced Monday that it received a $20M milestone payment from its partner Melinta Therapeutics ( OTCPK:MLNTQ ) following the FDA approval of candidemia treatment Rezzayo last month. The U.S. approved the once we...
– U.S. launch of REZZAYO by Melinta expected in mid-2023 – – Company eligible to receive up to an additional $47 million in milestones from multiple existing partnerships based on successful completion of activities planned over the next year – SAN DIEGO, A...
2023-03-29 11:28:16 ET With so much volatility in the stock market today, you may consider penny stocks an option. These stocks are typically priced under $5 and are known for extreme price fluctuations. They are also known for their potential for high returns. With that, they come with sig...
2023-03-28 08:24:33 ET Viking Therapeutics ( VKTX ) +46% jumps 39% on early-stage data for obesity candidate. Oscar Health ( OSCR ) +27% rises on CEO appointment. Intra-Cellular Therapies ( ITCI ) +15% Announces Positive Topline Results from S...
2023-03-24 12:20:59 ET Gainers: Silvergate Capital Corporation ( SI ) +66% . NaaS Technology ( NAAS ) +36% . Assure Holdings ( IONM ) +21% . Dermata Therapeutics ( DRMA ) +21% . ReNew Energy Global ( RNW ) +20% . GH Research ...
2023-03-24 10:01:43 ET Gainers: Dermata Therapeutics ( DRMA ) +40% . GH Research ( GHRS ) +27% . Vaccitech ( VACC ) +25% . Cosmos Health ( COSM ) +10% . Assure ( IONM ) +6% . Losers: BridgeBio Pharma ( BBIO ) -9%...
2023-03-23 15:43:20 ET Despite strong gains early this week, antifungal drug developers lost steam on Thursday even after Cidara Therapeutics ( NASDAQ: CDTX ) won FDA approval for its candidemia treatment Rezzayo. Shares of Cidara ( CDTX ) and its rival in antifungal s...
SAN FRANCISCO and BOSTON, March 23, 2023 (GLOBE NEWSWIRE) -- 5AM Ventures is pleased that the U.S. Food and Drug Administration (FDA) approved REZZAYO™ (rezafungin for injection) for the treatment of candidemia and invasive candidiasis in adults with limited or no alternative treatmen...
2023-03-23 10:06:23 ET Gainers: ZyVersa Therapeutics ( ZVSA ) +33% . Aziyo Biologics ( AZYO ) +29% . Generation Bio ( GBIO ) +20% . HTG Molecular Diagnostics ( HTGM ) +16% . scPharmaceuticals ( SCPH ) +15% . Losers:...
News, Short Squeeze, Breakout and More Instantly...
Cidara Therapeutics Inc. Company Name:
CDTX Stock Symbol:
NASDAQ Market:
Cidara Therapeutics Inc. Website:
2024-07-16 23:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious...
SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients ...